跳至主要内容
临床试验/JPRN-UMIN000014522
JPRN-UMIN000014522招募中2 期

The assessment of efficacy and safety of Irreversible Electroporation(IRE) to treat hepatic malignancies - IRE to treat hepatic malignancies

Tokyo Medical University0 个研究点目标入组 20 人开始时间: 2014年7月9日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Uncontrolled infection, 2. Heart failure, coronary artery disease or arrhythmia in progress, active implantable devices (eg pacemaker), 3. Pregnant women or women of childbearing potential not using an acceptable method of contraception, 4. Patient's disability to stop anticoagulant and antiplatelet therapy, 5. In the opinion of the researcher, anyone who cannot follow the calender of vist and asessment of the Protocol, 6. Patient received systemic chemotherapy within 4 weeks of treatment with the IRE NanoKnife,

研究者

相似试验